TP 53 status and estrogen receptor-beta in triple negative breast cancer management in Africa: Time to rethink regime management of triple negative breast cancer and save more lives in Nigeria

TP 53 status and estrogen receptor-beta in triple negative breast cancer management in Africa: Time to rethink regime management of triple negative breast cancer and save more lives in Nigeria

Bibliographic Details
Main Authors:	Martin Arinzechukwu Nzegwu, Onyekachi Nwokoro, Christian Nnamani, Vincent C Enemuo, Victor Ifeanyichukwu Nzegwu, Ogochukwu Nwoye, Anthony Edeh, Kenneth Nwankwo
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-10-01
Series:	Rare Tumors
Online Access:	https://doi.org/10.1177/20363613211050355

Similar Items

Impact of TP53 mutations in Triple Negative Breast Cancer
by: Zahi I. Mitri, et al.
Published: (2022-09-01)

Management Options in Triple-Negative Breast Cancer
by: Christina A. Minami, et al.
Published: (2011-07-01)

Management Options in Triple-Negative Breast Cancer
by: Christina A. Minami, et al.
Published: (2011-01-01)

Management of triple negative breast cancer in a centenarian
by: Andrew Donaldson, et al.
Published: (2022-09-01)

Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer
by: Kun Sun, et al.
Published: (2023-03-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Theranostics for Triple-Negative Breast Cancer
by: Hyeryeon Choi, et al.
Published: (2023-01-01)

Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021-11-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Advances in the Management of Early-Stage Triple-Negative Breast Cancer
by: Prarthna V. Bhardwaj, et al.
Published: (2023-08-01)

Update on triple-negative breast cancer: prognosis and management strategies
by: Brouckaert O, et al.
Published: (2012-09-01)

Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer
by: Leandra Fiori Lopes, et al.
Published: (2014-12-01)

Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
by: Rajesh Pradhan, et al.
Published: (2023-01-01)

Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
by: Gorenšek R, et al.
Published: (2023-11-01)

Curcumin–Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer
by: Khaled Greish, et al.
Published: (2018-11-01)

Locoregional treatments for triple-negative breast cancer.
by: Eiermann, W, et al.
Published: (2012)

Advanced Triple Negative Breast Cancer in Pregnancy
by: Tze Huat Chong, et al.
Published: (2020)

Immunohistochemical Differentiation of Triple Negative Breast Cancer
by: Miroslav Lesar, et al.
Published: (2016-01-01)

Hot issues in triple-negative breast cancer
by: Xiaopeng Hao, et al.
Published: (2023-12-01)

Triple negative breast cancer: Pitfalls and progress
by: Paola Zagami, et al.
Published: (2022-08-01)

Advances in immunotherapy for triple-negative breast cancer
by: Yang Liu, et al.
Published: (2023-09-01)

Drug Repurposing for Triple-Negative Breast Cancer
by: Marta Ávalos-Moreno, et al.
Published: (2020-10-01)

Estrogen Actions in Triple-Negative Breast Cancer
by: Oliver Treeck, et al.
Published: (2020-10-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01)

PDJ amplicon in triple negative breast cancer
by: Alexander S. Roesler, et al.
Published: (2023-01-01)

Advances in Treatment of Triple Negative Breast Cancer
by: KANG Yikun, et al.
Published: (2022-08-01)

Metabolic Reprogramming in Triple-Negative Breast Cancer
by: Xiangyu Sun, et al.
Published: (2020-03-01)

Effect of cisplatin on triple negative breast cancer /
by: Hend Salaheldien Ahmed Elnour, 1986-, author 611422
Published: (2017)

Effect of cisplatin on triple negative breast cancer /
by: Hend Salaheldien Ahmed Elnour, 1986-, author 611422, et al.
Published: (2017)

Sonographic Features of Triple Negative Breast Cancer
by: Fei Li, MD, Bei Wang, MD, Hongyu Ding, MD, Hongjun Sun, MD
Published: (2018-03-01)

The Proteomic Landscape of Triple-Negative Breast Cancer
by: Robert T. Lawrence, et al.
Published: (2015-05-01)

Clinicopathological Study of Triple Negative Breast Cancers
by: Gunadala Ishitha, et al.
Published: (2016-09-01)

Metabolic reprogramming in triple-negative breast cancer
by: Zhanyu Wang, et al.
Published: (2020-02-01)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
by: Dan Qiu, et al.
Published: (2022-01-01)

Immunotherapeutic interventions of Triple Negative Breast Cancer
by: Zehuan Li, et al.
Published: (2018-05-01)

Nanomaterial Technology and Triple Negative Breast Cancer
by: Kai Hou, et al.
Published: (2022-01-01)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer
by: Domenico Ribatti, et al.
Published: (2016-10-01)

A triple negative breast cancer: what it is not!
by: Katakkar SB
Published: (2012-02-01)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
by: Jiande Wu, et al.
Published: (2020-06-01)